FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, virology and medicine. There is disclosed a composition that aims at elicitation of an anti-HIV immune response. The composition contains one mytistate-binding site covalently linked with HIV matrix protein. The composition allows to elicit an effective anti-HIV immune response. Also there are disclosed an application of such composition for preparing a medicinal agent and a method of the immune response elicitation in animals.
EFFECT: invention can be used in medicine.
31 cl, 8 dwg
Authors
Dates
2010-11-20—Published
2004-10-25—Filed